Alteration of Dickkopf-1 and receptor activator of nuclear factor-κB ligand during PBSC mobilization in healthy donors by G-CSF

被引：0
|
作者：
M Tanaka
T Yujiri
Y Tanaka
N Mitani
A Tanimura
Y Tanizawa
机构：
[1] Yamaguchi University Graduate School of Medicine,Department of Bio
[2] Yamaguchi University School of Medicine,Signal Analysis
来源：
Bone Marrow Transplantation | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1143 / 1144
页数：1
相关论文
共 50 条
  • [31] Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-κB ligand by osteoblasts
    Deyama, Y
    Kikuiri, T
    Ohnishi, G
    Feng, YG
    Takeyama, S
    Hatta, M
    Yoshimura, Y
    Suzuki, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 298 (02) : 240 - 246
  • [32] Predicting the Efficacy of Novel Synthetic Compounds in the Treatment of Osteosarcoma via Anti-Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) Targets
    Zhang, Wenhua
    Xu, Siping
    Liu, Peng
    Li, Xusheng
    Yu, Xinyuan
    Kang, Bing
    MEDICINAL CHEMISTRY, 2024, 20 (07) : 733 - 740
  • [33] Receptor Activator of Nuclear Factor-κB Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis
    Atsushi Sasaki
    Kenji Ishikawa
    Naotsugu Haraguchi
    Hiroshi Inoue
    Tetsuya Ishio
    Kohei Shibata
    Masayuki Ohta
    Seigo Kitano
    Masaki Mori
    Annals of Surgical Oncology, 2007, 14 : 1191 - 1199
  • [34] Differential expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin mRNA in periodontal diseases
    Bostanci, N.
    Ilgenli, T.
    Emingil, G.
    Afacan, B.
    Han, B.
    Toz, H.
    Berdeli, A.
    Atilla, G.
    McKay, I. J.
    Hughes, F. J.
    Belibasakis, G. N.
    JOURNAL OF PERIODONTAL RESEARCH, 2007, 42 (04) : 287 - 293
  • [35] The role of the receptor activator of nuclear factor-κB ligand/osteoprotegerin cytokine system in primary hyperparathyroidism
    Nakchbandi, Inaam A.
    Lang, Robert
    Kinder, Barbara
    Insogna, Karl L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (03): : 967 - 973
  • [36] Receptor activator of nuclear Factor-κB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis
    Sasaki, Atsushi
    Ishikawa, Kenji
    Haraguchi, Naotsugu
    Inoue, Hiroshi
    Ishio, Tetsuya
    Shibata, Kohei
    Ohta, Masayuki
    Kitano, Seigo
    Mori, Masaki
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (03) : 1191 - 1199
  • [37] Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
    Trouvin, Anne-Priscille
    Goeb, Vincent
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 345 - 354
  • [38] Roles of receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in periodontal health and disease
    Nagasawa, Toshiyuki
    Kiji, Makoto
    Yashiro, Reiko
    Hormdee, Doosadee
    He, Lu
    Kunze, Melanie
    Suda, Tomonari
    Koshy, Geena
    Kobayashi, Hiroaki
    Oda, Shigeru
    Nitta, Hiroshi
    Ishikawa, Isao
    PERIODONTOLOGY 2000, 2007, 43 : 65 - 84
  • [39] The role of receptor activator of nuclear factor-κB (RANK)/RANK ligand/osteoprotegerin:: Clinical implications
    Vega, Damaris
    Maalouf, Naim M.
    Sakhaee, Khashayar
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (12): : 4514 - 4521
  • [40] Targeting the receptor activator of nuclear factor-κB (RANK) ligand in prostate cancer bone metastases
    Saad, Fred
    Markus, Richard
    Goessl, Carsten
    BJU INTERNATIONAL, 2008, 101 (09) : 1071 - 1075
12345